SCHEMBL24449318

SCHEMBL24449318

CC(C)c1cncn(Cc2c(Cl)cc(NC(=O)OC(C)(C)C)cc2Cl)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 3/20 0.37
▸ P2RX3 P56373 2/20 0.36
▸ THRA P10827 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ CYP17A1 P05093 2/20 0.35
▸ PTGDR2 Q9Y5Y4 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ SCD O00767 1/20 0.34
▸ HDAC3 O15379 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ NCOR2 Q9Y618 1/20 0.33
▸ MAPKAPK2 P49137 1/20 0.33
▸ PTGER1 P34995 1/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ AAK1 Q2M2I8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24449316 0.78 PTGDR2 (0.37) IDO1P2RX3THRATHRBCYP17A1
SCHEMBL24449323 0.76 HSP90AA1 (0.34) THRATHRBALDH1A1
SCHEMBL28559669 0.74 THRB (0.47) P2RX3THRATHRBCYP17A1PTGDR2
SCHEMBL28566363 0.71 PTGDR2 (0.42) P2RX3THRBCYP17A1PTGDR2KDM4E
SCHEMBL28913436 0.69 THRB (0.62) THRATHRB
SCHEMBL28560603 0.69 THRB (0.64) THRATHRB
SCHEMBL28561278 0.68 THRB (0.42) THRATHRB
SCHEMBL8571236 0.67 CA12 (0.43) CYP17A1HDAC3HDAC8MAPKAPK2NAMPT
SCHEMBL24449312 0.66 CA12 (0.45) CYP17A1PTGDR2CYP2C9CYP2C19MAPKAPK2
SCHEMBL282268 0.66 DHODH (0.45) CYP17A1KDM4EALDH1A1MAPKAPK2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220162161-A1 Novel compounds and their uses as thyroid hormone receptor agonists NANJING RUIJIE PHARMA CO., LTD. (CN) 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162161-A1 Novel compounds and their uses as thyroid hormone receptor agonists THRA, THRB, TSHR IDO1 1766/4885P2RX3 4031/4885THRA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback